Forsta Ap Fonden Abb Vie Inc. Transaction History

Forsta Ap Fonden

$12.8 Billion
Q3 2024

A detailed history of Forsta Ap Fonden transactions in Abb Vie Inc. stock. As of the latest transaction made, Forsta Ap Fonden holds 452,762 shares of ABBV stock, worth $79.5 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

452,762

Previous 412,762 9.69%

Holding current value

$79.5 Million

Previous $70.8 Million 26.29%

% of portfolio

0.7%

Previous 0.63%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $6.55 Million - $7.97 Million	40,000 Added 9.69%	452,762 $89.4 Million
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $4.61 Million - $5.39 Million	-29,800 Reduced 6.73%	412,762 $70.8 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $1.73 Million - $1.97 Million	-10,800 Reduced 2.38%	442,562 $80.6 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $4.33 Million - $4.88 Million	-31,500 Reduced 6.5%	453,362 $70.3 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $26,718 - $30,930	-200 Reduced 0.04%	484,862 $72.3 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $2.86 Million - $3.56 Million	21,600 Added 4.66%	485,062 $65.4 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $1.34 Million - $1.55 Million	-9,300 Reduced 1.97%	463,462 $73.9 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $6.79 Million - $8.14 Million	49,100 Added 11.59%	472,762 $76.5 Million
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $93,947 - $107,751	-700 Reduced 0.16%	423,662 $56.9 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $1.98 Million - $2.52 Million	-14,400 Reduced 3.28%	424,362 $65 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $2.89 Million - $3.59 Million	21,900 Added 5.25%	438,762 $71.1 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $977,613 - $1.24 Million	-9,100 Reduced 2.14%	416,862 $56.4 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $4.75 Million - $5.39 Million	44,600 Added 11.69%	425,962 $45.9 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $4.79 Million - $5.33 Million	45,500 Added 13.55%	381,362 $43 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $971,850 - $1.07 Million	9,500 Added 2.91%	335,862 $36.3 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $1.56 Million - $2.11 Million	19,400 Added 6.32%	326,362 $35 Million
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $6.32 Million - $7.42 Million	73,600 Added 31.54%	306,962 $26.9 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $4.89 Million - $6.54 Million	66,662 Added 39.99%	233,362 $22.9 Million
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $10.8 Million - $16.3 Million	166,700 New	166,700 $12.7 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account